ArticleOncology letters2015

Synergistic interaction between MEK inhibitor and gefitinib in EGFR-TKI-resistant human lung cancer cells.

Suxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.